Skip to main content

Endothelin-1(1–31) Induces Spreading Depolarization in Rats

  • Conference paper
Early Brain Injury or Cerebral Vasospasm

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 110/1))

  • 1423 Accesses

Abstract

Background: The vasoconstrictor endothelin-1(1–21) (ET-1) seems to induce cerebral vasospasm after aneurismal subarachnoid hemorrhage (aSAH). Moreover, ET-1 causes spreading depolarization (SD) via vasoconstriction/ischemia. ET-1(1–31) is an alternate metabolic intermediate in the generation of ET-1. Our aim was to investigate whether endothelin-1(1–31) causes SD in a similar fashion to ET-1.

Method: Increasing concentrations of either ET-1, ET-1(1–31) or vehicle were brain topically applied in 29 rats. Each concentration was superfused for one hour while regional cerebral blood flow (rCBF) and direct current electrocorticogram (DC-ECoG) were recorded.

Findings: In response to the highest concentration of 10-−6M, all animals of both ET groups developed typical SD. At concentrations below 10-−6M only ET-1 induced SD (n = 14 of 19 rats). Thus, the efficacy of ET-1(1–31) to induce SD was significantly lower (P < 0.001, two-tailed Fisher’s Exact Test).

Conclusions: Our findings suggest that ET-1(1–31) less potently induces SD compared to ET-1 which implicates that it is a less potent vasoconstrictor. Speculatively, it could be interesting to shift the metabolic pathway towards the alternate intermediate ET-1(1–31) after aSAH as an alternative strategy to ETA receptor inhibition. This could decrease ET-induced vasoconstriction and SD generation while a potentially beneficial basal ETA receptor activation is maintained.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 1983;33:424–36.

    Article  PubMed  CAS  Google Scholar 

  2. Pluta RM, Afshar JK, Boock RJ, Oldfield EH. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg. 1998;88:557–61.

    Article  PubMed  CAS  Google Scholar 

  3. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 2007;3:256–63.

    Article  PubMed  CAS  Google Scholar 

  4. Schuknecht B, Fandino J, Yuksel C, Yonekawa Y, Valavanis A. Endovascular treatment of cerebral vasospasm: assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology 1999;41:453–62.

    Article  PubMed  CAS  Google Scholar 

  5. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621–27.

    Article  PubMed  CAS  Google Scholar 

  6. Dreier JP, Korner K, Ebert N, Gorner A, Rubin I, Back T, et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab. 1998;18:978–90.

    Article  PubMed  CAS  Google Scholar 

  7. Dreier JP, Major S, Manning A, Woitzik J, Drenckhahn C, Steinbrink J, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009;132:1866–81.

    Article  PubMed  Google Scholar 

  8. Zimmermann MMD, Seifert VMDP. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 1998;43:863–75.

    Article  PubMed  CAS  Google Scholar 

  9. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin-1-induced reductions in cerebral blood-flow – dose dependency, time course, and neuropathological consequences. J Cereb Blood Flow Metab. 1993;13:276–84.

    Article  PubMed  CAS  Google Scholar 

  10. Fuxe K, Bjelke B, Andbjer B, Grahn H, Rimondini R, Agnati LF. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport 1997;8:2623–29.

    Article  PubMed  CAS  Google Scholar 

  11. Dreier JP, Kleeberg J, Alam M, Major S, Kohl-Bareis M, Petzold GC, et al. Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis. Exp Biol Med (Maywood). 2007;232:204–13.

    CAS  Google Scholar 

  12. Chow M, Dumont AS, Kassell NF. Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 2002;51:1333–41; discussion 1342.

    PubMed  Google Scholar 

  13. Vatter H, Konczalla J, Weidauer S, Preibisch C, Zimmermann M, Raabe A, et al. Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function. J Neurosurg. 2007;107:121–27.

    Article  PubMed  Google Scholar 

  14. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015–21.

    Article  PubMed  CAS  Google Scholar 

  15. Dreier JP, Petzold G, Tille K, Lindauer U, Arnold G, Heinemann U, et al. Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats. J Physiol. 2001;531:515–26.

    Article  PubMed  CAS  Google Scholar 

  16. Petzold GC, Einhaupl KM, Dirnagl U, Dreier JP. Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol. 2003;54:591–98.

    Article  PubMed  CAS  Google Scholar 

  17. Cosenzi A. Enrasentan, an antagonist of endothelin receptors. Cardiovasc Drug Rev. 2003;21:1–16.

    Article  PubMed  CAS  Google Scholar 

  18. D’Orleans-Juste P, Plante M, Honore JC, Carrier E, Labonte J. Synthesis and degradation of endothelin-1. Can J Physiol Pharmacol. 2003;81:503–10.

    Article  PubMed  Google Scholar 

  19. Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol. 1997;159:1987–92.

    PubMed  CAS  Google Scholar 

  20. Fecteau MH, Honore JC, Plante M, Labonte J, Rae GA, D’Orleans-Juste P. Endothelin-1 (1–31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 2005;46:87–92.

    Article  PubMed  CAS  Google Scholar 

  21. Baltatu O, Nishimura H, Hoffmann S, Stoltenburg G, Haulica ID, Lippoldt A, et al. High levels of human chymase expression in the pineal and pituitary glands. Brain Res. 1997;752:269–78.

    Article  PubMed  CAS  Google Scholar 

  22. Dreier JP, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD, et al. Endothelin-1 potently induces Leao’s cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002;125:102–12.

    Article  PubMed  Google Scholar 

  23. Kleeberg J, Petzold GC, Major S, Dirnagl U, Dreier JP. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol. 2004;286:H1339–46.

    Article  PubMed  CAS  Google Scholar 

  24. Leslie SJ, Rahman MQ, Denvir MA, Newby DE, Webb DJ. Endothelins and their inhibition in the human skin microcirculation: ET[1–31], a new vasoconstrictor peptide. Br J Clin Pharmacol. 2004;57:720–25.

    Article  PubMed  CAS  Google Scholar 

  25. Maguire JJ, Kuc RE, Davenport AP. Vasoconstrictor activity of novel endothelin peptide, ET-1(1–31), in human mammary and coronary arteries in vitro. Br J Pharmacol. 2001;134:1360–66.

    Article  PubMed  CAS  Google Scholar 

  26. Somjen GG. Ions in the brain. Normal function, seizures and stroke. New York: Oxford University Press; 2004.

    Google Scholar 

  27. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006;129:3224–37.

    Article  PubMed  Google Scholar 

  28. Dohmen C, Sakowitz OW, Fabricius M, Bosche B, Reithmeier T, Ernestus RI, et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008;63:720–28.

    Article  PubMed  Google Scholar 

  29. Mies G, Paschen W. Regional changes of blood flow, glucose, and ATP content determined on brain sections during a single passage of spreading depression in rat brain cortex. Exp Neurol. 1984;84:249–58.

    Article  PubMed  CAS  Google Scholar 

  30. Busch E, Gyngell ML, Eis M, Hoehn-Berlage M, Hossmann KA. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging. J Cereb Blood Flow Metab. 1996;16:1090–99.

    Article  PubMed  CAS  Google Scholar 

  31. Koroleva VI, Bures J. Circulation of cortical spreading depression around electrically stimulated areas and epileptic foci in the neocortex of rats. Brain Res. 1979;173:209–15.

    Article  PubMed  CAS  Google Scholar 

  32. Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab. 1993;13:568–74.

    Article  PubMed  CAS  Google Scholar 

  33. Takano K, Latour LL, Formato JE, Carano RA, Helmer KG, Hasegawa Y, et al. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol. 1996;39:308–18.

    Article  PubMed  CAS  Google Scholar 

  34. Kasuya H, Weir BK, White DM, Stefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg. 1993;79:892–98.

    Article  PubMed  CAS  Google Scholar 

  35. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg. 1992;77:274–78.

    Article  PubMed  CAS  Google Scholar 

  36. Schini VB, Hendrickson H, Heublein DM, Burnett JC, Jr., Vanhoutte PM. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol. 1989;165:333–34.

    Article  PubMed  CAS  Google Scholar 

  37. Xie A, Aihara Y, Bouryi VA, Nikitina E, Jahromi BS, Zhang ZD, et al. Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2007;27:1692–701.

    Article  PubMed  CAS  Google Scholar 

  38. Kastner S, Oertel MF, Scharbrodt W, Krause M, Boker DK, Deinsberger W. Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH. Acta Neurochir (Wien). 2005;147:1271–79; discussion 1279.

    Article  CAS  Google Scholar 

  39. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, et al. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 1997;87:287–93.

    Article  PubMed  CAS  Google Scholar 

  40. Mascia L, Fedorko L, Stewart DJ, Mohamed F, terBrugge K, Ranieri VM, et al. Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001;32:1185–90.

    Article  PubMed  CAS  Google Scholar 

  41. Yoshizumi M, Inui D, Okishima N, Houchi H, Tsuchiya K, Wakabayashi H, et al. Endothelin-1-(1–31), a novel vasoactive peptide, increases [Ca2+]i in human coronary artery smooth muscle cells. Eur J Pharmacol. 1998;348:305–9.

    Article  PubMed  CAS  Google Scholar 

  42. Yoshizumi M, Kim S, Kagami S, Hamaguchi A, Tsuchiya K, Houchi H, et al. Effect of endothelin-1 (1–31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol. 1998;125:1019–27.

    Article  PubMed  CAS  Google Scholar 

  43. Rossi GP, Andreis PG, Colonna S, Albertin G, Aragona F, Belloni AS, et al. Endothelin-1[1–31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth. J Clin Endocrinol Metab. 2002;87:322–28.

    Article  PubMed  CAS  Google Scholar 

  44. Hayasaki-Kajiwara Y, Naya N, Shimamura T, Iwasaki T, Nakajima M. Endothelin generating pathway through endothelin1–31 in human cultured bronchial smooth muscle cells. Br J Pharmacol. 1999;127:1415–21.

    Article  PubMed  CAS  Google Scholar 

  45. Lu Y, Wang LG, Liao Z, Tang CS, Wang WZ, Yuan WJ. Cardiovascular effects of centrally applied endothelin-1 1–31 and its relationship to endothelin-1 1–21 in rats. Auton Neurosci. 2007;133:146–52.

    Article  PubMed  CAS  Google Scholar 

  46. Wada A, Tsutamoto T, Ohnishi M, Sawaki M, Fukai D, Maeda Y, et al. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism. Circulation 1999;99:570–77.

    Article  PubMed  CAS  Google Scholar 

  47. Strbian D, Kovanen PT, Karjalainen-Lindsberg ML, Tatlisumak T, Lindsberg PJ. An emerging role of mast cells in cerebral ischemia and hemorrhage. Ann Med. 2009;1:1–13

    Google Scholar 

  48. Cui P, Tani K, Kitamura H, Okumura Y, Yano M, Inui D, et al. A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J Leukoc Biol. 2001;70:306–12.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

Supported by grants of the Deutsche Forschungsgemeinschaft (DFG DR 323/2–2), the Bundesministerium für Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801) and the Kompetenznetz Schlaganfall to Dr. Dreier.

Conflict of interest statement We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. P. Dreier .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this paper

Cite this paper

Jorks, D., Major, S., Oliveira-Ferreira, A.I., Kleeberg, J., Dreier, J.P. (2011). Endothelin-1(1–31) Induces Spreading Depolarization in Rats. In: Feng, H., Mao, Y., Zhang, J.H. (eds) Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements, vol 110/1. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0353-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0353-1_20

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0352-4

  • Online ISBN: 978-3-7091-0353-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics